UROLOGIC CANCER
Clinical trials for UROLOGIC CANCER explained in plain language.
Never miss a new study
Get alerted when new UROLOGIC CANCER trials appear
Sign up with your email to follow new studies for UROLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder treatment aims to stop Cancer's return, spare patients major surgery
Disease control Not yet recruitingThis Phase 3 study is testing a new drug called NDV-01 for people with non-muscle invasive bladder cancer (NMIBC). It aims to see if putting the drug directly into the bladder can prevent the cancer from coming back and stop it from getting worse, which could help patients avoid …
Matched conditions: UROLOGIC CANCER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New scan could spot aggressive kidney cancers earlier
Diagnosis Not yet recruitingThis study aims to see if MRI scans can better identify invasive cancers in the upper urinary tract (kidneys and ureters) compared to current CT scans. Researchers will enroll 178 adults with suspected tumors and compare MRI results with tissue analysis to determine accuracy. The…
Matched conditions: UROLOGIC CANCER
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
New program aims to ease painful side effects for women after pelvic cancer treatment
Symptom relief Not yet recruitingThis study is testing a new support program designed to help women who have had pelvic radiation therapy use vaginal dilators more consistently. Vaginal dilators can help prevent painful narrowing of the vagina, a common side effect of radiation, but many women struggle to use th…
Matched conditions: UROLOGIC CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC